RhumbLine Advisers’s Global Cord Blood Corporation CO Stock Holding History

RhumbLine Advisers’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14K	Hold	13,362	–	–	﹤0.01%	3764
2025 Q4	$12.7K	Hold	13,362	–	–	﹤0.01%	3823
2025 Q3	$13.5K	Sell	13,362 -11,455	-46%	-$11.6K	﹤0.01%	3825
2025 Q2	$37.2K	Hold	24,817	–	–	﹤0.01%	3717
2025 Q1	$22.3K	Sell	24,817 -19,940	-45%	-$17.9K	﹤0.01%	3722
2024 Q4	$67.1K	Hold	44,757	–	–	﹤0.01%	3588
2024 Q3	$78.3K	Hold	44,757	–	–	﹤0.01%	3582
2024 Q2	$51.5K	Sell	44,757 -7,937	-15%	-$9.13K	﹤0.01%	3672
2024 Q1	$71.1K	Hold	52,694	–	–	﹤0.01%	3541
2023 Q4	$64.3K	Buy	52,694 +7,937	+18%	+$9.68K	﹤0.01%	3570
2023 Q3	$55.5K	Hold	44,757	–	–	﹤0.01%	3621
2023 Q2	$47K	Buy	+44,757	New	+$47K	﹤0.01%	3685

RhumbLine Advisers's CO Position: Q1 2026 in Review

RhumbLine Advisers held its Global Cord Blood Corporation (CO) position steady in Q1 2026 at 13,362 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3764.

RhumbLine Advisers first reported a position in CO in Q2 2023 and has held it in 12 quarters since. The position peaked at $78.3K in Q3 2024. 1 fund tracked by Wall St. Rank holds CO as of Q1 2026.

RhumbLine Advisers held 13,362 shares of Global Cord Blood Corporation worth $14K as of Q1 2026.
RhumbLine Advisers left its Global Cord Blood Corporation share count unchanged in Q1 2026.
Global Cord Blood Corporation made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3764 holding.
RhumbLine Advisers first reported a position in Global Cord Blood Corporation in Q2 2023 and has held it in 12 quarters since.
RhumbLine Advisers's Global Cord Blood Corporation position peaked at $78.3K in Q3 2024.
1 fund tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.